Formiminotransferase domain, N-terminal subdomain | |||||||||
---|---|---|---|---|---|---|---|---|---|
![]() the crystal structure of the formiminotransferase domain of formiminotransferase-cyclodeaminase.
|
|||||||||
Identifiers | |||||||||
Symbol | FTCD_N | ||||||||
Pfam | PF07837 | ||||||||
InterPro | IPR012886 | ||||||||
SCOP | 1qd1 | ||||||||
SUPERFAMILY | 1qd1 | ||||||||
|
Available protein structures: | |
---|---|
Pfam | structures |
PDB | RCSB PDB; PDBe; PDBj |
PDBsum | structure summary |
Formiminotransferase domain | |||||||||
---|---|---|---|---|---|---|---|---|---|
![]() the crystal structure of the formiminotransferase domain of formiminotransferase-cyclodeaminase.
|
|||||||||
Identifiers | |||||||||
Symbol | FTCD | ||||||||
Pfam | PF02971 | ||||||||
InterPro | IPR013802 | ||||||||
SCOP | 1qd1 | ||||||||
SUPERFAMILY | 1qd1 | ||||||||
|
Available protein structures: | |
---|---|
Pfam | structures |
PDB | RCSB PDB; PDBe; PDBj |
PDBsum | structure summary |
Glutamate formimidoyltransferase is a methyltransferase enzyme which uses tetrahydrofolate as part of histidine catabolism. It catalyses two reactions:
It is classified under EC 2.1.2.5 and in mammals is found as part of a bifunctional enzyme that also has formimidoyltetrahydrofolate cyclodeaminase activity.
The formiminotransferase (FT) domain of formiminotransferase-cyclodeaminase (FTCD) forms a homodimer, with each protomer comprising two subdomains. The formiminotransferase domain has an N-terminal subdomain that is made up of a six-stranded mixed beta-pleated sheet and five alpha helices, which are arranged on the external surface of the beta sheet. This, in turn, faces the beta-sheet of the C-terminal subdomain to form a double beta-sheet layer. The two subdomains are separated by a short linker sequence, which is not thought to be any more flexible than the remainder of the molecule. The substrate is predicted to form a number of contacts with residues found in both the N-terminal and C-terminal subdomains. In humans, deficiency of this enzyme results in a disease phenotype.
This article incorporates text from the public domain Pfam and InterPro IPR013802